Ameriprise Financial Inc. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 751,090 shares of the exchange traded fund’s stock after selling 96,730 shares during the period. Ameriprise Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $67,643,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at about $29,000. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC increased its stake in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $38,000. Finally, Bank of Jackson Hole Trust purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $43,000.
SPDR S&P Biotech ETF Stock Performance
SPDR S&P Biotech ETF stock opened at $76.39 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The company has a market capitalization of $4.85 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. The stock has a fifty day moving average of $80.77 and a two-hundred day moving average of $89.27.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Golden Cross Stocks: Pattern, Examples and Charts
- Google Is Betting Big on Nuclear Reactors—Should You?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Overbought Stocks Explained: Should You Trade Them?
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.